Skip to main content
Livermore
Livermore
ZHEN

Hyperion Capital Advisors LP

SEC CIK
0001794499
Latest filing
Aug 13, 2026

WST holding history

West Pharmaceutical Services Inc in every 13F filed by Hyperion Capital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WST overviewAll 13F holders of WSTFull Q2 2026 holdings

Shares (Q2 2026)
2,029
Value
$728.4K
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of WST by Hyperion Capital Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,029$728.4K0.3%−101−4.7%ReducedHolders
Q1 20262,130$533.9K0.3%00.0%UnchangedHolders
Q4 20252,130$586.0K0.3%00.0%UnchangedHolders
Q3 20252,130$558.8K0.3%00.0%UnchangedHolders
Q2 20252,130$466.0K0.3%00.0%UnchangedHolders
Q1 20252,130$476.9K0.3%00.0%UnchangedHolders
Q4 20242,130$697.7K0.4%−31−1.4%ReducedHolders
Q3 20242,161$648.6K0.3%00.0%UnchangedHolders
Q2 20242,161$711.8K0.3%00.0%UnchangedHolders
Q1 20242,161$855.1K0.4%00.0%UnchangedHolders
Q4 20232,161$760.9K0.4%−88−3.9%ReducedHolders
Q3 20232,249$843.8K0.5%00.0%UnchangedHolders
Q2 20232,249$860.2K0.5%00.0%UnchangedHolders
Q1 20232,249$779.2K0.4%00.0%UnchangedHolders
Q4 20222,249$529.3K0.3%00.0%UnchangedHolders
Q3 20222,249$553.0K0.3%00.0%UnchangedHolders
Q2 20222,249$680.0K0.3%00.0%UnchangedHolders
Q1 20222,249$924.0K0.4%00.0%UnchangedHolders
Q4 20212,249$1.05M0.2%−92−3.9%ReducedHolders
Q3 20212,341$994.0K0.3%00.0%UnchangedHolders
Q2 20212,341$841.0K0.2%−46−1.9%ReducedHolders
Q1 20212,387$673.0K0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.